PGE-24509-04574
4 vaccinations
4 coded responses
35 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 350 / AL
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body achesAdult check-in
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · HeadacheAdult check-in
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
-
2021-04-20
Dose 2 — Pfizer-BioNTech
- 2021-04-20
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
-
2021-07-26
Survey response — 3 months, dose 2MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-20
Survey response — 6 months, dose 2MedDRA: Renal disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Dr stated I have a kidney issueMedDRA releases: 2024-11 · check-in free text available
-
2021-10-20
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-22
-
2021-11-04
Dose 3 — Pfizer-BioNTech
- 2022-04-20
-
2022-04-29
Dose 4 — Pfizer-BioNTech
- 2022-04-30
- 2022-05-01
-
2022-05-02
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-05-03
- 2022-05-06
- 2022-05-15
- 2022-05-20
- 2022-05-27
- 2022-06-05
- 2022-06-10
- 2022-07-29
-
2022-10-28
Survey response — 6 months, dose 4MedDRA: Unevaluable event, Uterine leiomyoma — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Fibroids · Healthcare visit (other): UltrasoundMedDRA releases: 2024-11 · check-in free text available
-
2022-10-28
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-31
- 2022-10-31
-
2023-05-01
Survey response — 12 months, dose 4MedDRA: Diabetes mellitus — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-05-01
Report sent to call center — 12 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-05-02
- 2023-05-02
- 2023-05-02
- 2023-05-05
- 2023-05-05
- 2023-05-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-11-04 | Pfizer-BioNTech | No |
| 4 | 2022-04-29 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 9 — 3 months, dose 2
Symptoms: Headache
Release 10 — 6 months, dose 2
Symptoms: Dr stated I have a kidney issue
Release 12 — 6 months, dose 4
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Diabetes mellitus | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Renal disorder | · | · | ✓ |
| SD | Uterine leiomyoma | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release